Press release
Active Pharmaceutical Ingredient Market to grow significantly witnessing a CAGR
Active pharmaceutical ingredients are drugs used for chronic diseases such as neuropathic pain, pulmonary diseases, cancer, diabetes, and heart diseases. However, these ingredients have both, benefits as well as adverse effects.Pharma companies have focused on modernizing their manufacturing methods to improve overall product quality. This also means automation in process development, something that was previously done manually. Installing equipment with large capacities in terms of volume also enables greater production yield.
According to the revised report published by Persistence Market Research, the global active pharmaceutical ingredient market valued at around US$ 180 Bn in 2020, and is predicted to expand at a CAGR of more than 4% over the forecast period (2021-2031).
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/11260
Company profiles:
• Pfizer Inc.
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• Cipla Inc.
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline plc
• Hepalink Group
• Lonza
• Merck & Co. Inc.
• Sandoz International GmbH
• Aurobindo Pharma Limited
• Fresenius Kabi LLC
Request for Methodology @ https://www.persistencemarketresearch.com/methodology/11260
Key Takeaways from Market Study
• Small molecule active pharmaceutical ingredients are expected to contribute more than 91% revenue share in the market by 2031, owing to their wide availability and potency to relieve moderate to severe pain, usually after a surgery or traumatic injury.
• Non-controlled substances are expected to account for more than half of the global market share.
• Among all the end users, pharmaceutical companies accounted for more market share than others.
• East Asia holds the highest share in the global active pharmaceutical ingredient market, owing to the presence of more CMOs, high healthcare expenditure, and growing research & development efforts in the region.
• Key players are focused on strengthening their clinical pipelines with new discoveries of novel abuse-deterrent formulations.
• The market in the India is projected expand at a CAGR around 4% through 2021-2031. The U.S. holds a big portion of global revenue, and accounts for more than 87% share in the North America market.
"Strong growth in demand is being witnessed for small molecules, owing to their potency, efficacy, and safety," says an analyst of Persistence Market Research.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/11260
Increasing Healthcare Spending on Active Pharmaceutical Ingredients
Global healthcare spending increased at a CAGR of 6.92% from 2003 to 2013. This growth in healthcare spending significantly outpaced the growth rate of population in this period, which grew at a CAGR of 1.22%. Consequently, per capita healthcare spending increased from US$ 597 in 2003 to US$ 1,032 in 2013, increasing at a CAGR of 5.62%.
Rise in healthcare spending across all regions has increased access to quality healthcare, and is expected to continue to drive demand for pharmaceutical products.
• On 25 March 2019, TUL secured its position in the 2018 China TOP 10 Member Enterprises of APIs. The position was awarded to TUL for its excellent exporting and importing profile of API, pharmaceutical formulations, and Chinese medicines in 2018.
• In 2016, Novartis' Sandoz discontinued operations at its Maharashtra, India site, as part of global plans to optimize manufacturing. The site, located in west-central India, employed 170 people and manufactured antibiotics and APIs.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the active pharmaceutical ingredient market in its latest study, presenting historical demand assessment of 2016 - 2020 and projections for 2021 - 2031. The research study is based on API (small molecules, peptides & oligonucleotides, carbohydrate drugs, and steroidal drugs) and end user (contract manufacturing organizations (CMOs), pharmaceutical companies, contract development manufacturing organizations (CDMOs), and compounding pharmacies), across seven key regions of the world.
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Active Pharmaceutical Ingredient Market to grow significantly witnessing a CAGR here
News-ID: 2746296 • Views: …
More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market
The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and…

Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts.
Forged automotive components are critical to…

Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the…

Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…